Recordati stock holds firm as takeover talk lifts attention
Published on 08/31/2026 at 17:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Recordati stock (IT0003828271) traded at 52.55 EUR on Tradegate on August 28, 2026, while the current bid discussion centered on a 51.29 euro per share offer. The shares were down 0.38% on the session and up 8.17% year to date.
Offer terms and price gap
A report dated August 31, 2026 said the voluntary takeover offer for Recordati was set to run at 51.29 euros per share, with payment expected on October 23, 2026. Against that backdrop, the Tradegate quote leaves the stock 1.26 euros above the offer level, a 2.45% premium to the bid.
The deal angle gives investors a concrete reference point: a market price above the stated offer can signal that trading is already pricing in either execution risk, a higher bid, or both.
Latest reported numbers
Recordati's valuation page shows 2025 revenue at EUR 2.618 billion, EBITDA at EUR 991.1 million, EBIT at EUR 774.9 million, and net profit at EUR 443.6 million. Net debt stood at EUR 2.037 billion in 2025 and EUR 1.750 billion in 2026 estimates, while the 2026 estimate for revenue is EUR 2.788 billion.
That puts the business on a clear scale: 2025 revenue rose from EUR 2.342 billion in 2024, EBITDA increased from EUR 865.8 million, and net debt improved from EUR 2.037 billion to EUR 1.750 billion in the 2026 estimate. The numbers show a steadier balance sheet than the prior year and a higher top-line base than the 2024 comparison.
Product angle
Recordati's portfolio includes branded prescription medicines across specialty and primary care, with oncology, rare diseases, and consumer health among its main areas. That mix matters because the offer debate is being judged against a business that already generated EUR 2.618 billion in 2025 revenue and EUR 991.1 million in EBITDA.
Trading level
The stock closed at 52.55 EUR on Tradegate on August 28, 2026, with a 52-week range shown at 43.24 to 60.00 EUR and a 2026 gain of 8.17%. In that frame, Recordati stock is trading closer to the upper half of its one-year band than to the low end.
More on Recordati stock
Company: Recordati S.p.A.
ISIN: IT0003828271
Ticker: RER1
Exchange: Tradegate
Price (as of August 28, 2026, 10:02 p.m. ET): EUR 52.55
Market cap: EUR 10.783 billion (as of August 31, 2026)
Sector / Industry: Health Care / Pharmaceuticals
Index membership: FTSE MIB
What the stock is doing
Recordati stock is trading with a market value of EUR 10.783 billion and a 2026 gain of 8.17% against a 52.55 euro Tradegate quote. The latest reported 2025 fundamentals and the August 31 takeover report leave the shares anchored between operating results and deal terms.
